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Abstract
The mechanisms that regulate the switch between epidermal
progenitor state and differentiation are not fully understood.
Recent findings indicate that the chromatin remodelling BAF
complex (Brg1-associated factor complex or SWI/SNF complex) and
the transcription factor p63 mutually recruit one another to open
chromatin during epidermal differentiation. Here, we identify a
long non-coding transcript that includes an ultraconserved
element, uc.291, which physically interacts with ACTL6A and
modulates chromatin remodelling to allow differentiation. Loss of
uc.291 expression, both in primary keratinocytes and in three-
dimensional skin equivalents, inhibits differentiation as indicated
by epidermal differentiation complex genes down-regulation. ChIP
experiments reveal that upon uc.291 depletion, ACTL6A is bound to
the differentiation gene promoters and inhibits BAF complex
targeting to induce terminal differentiation genes. In the presence
of uc.291, the ACTL6A inhibitory effect is released, allowing chro-
matin changes to promote the expression of differentiation genes.
Thus, uc.291 interacts with ACTL6A to modulate chromatin remod-
elling activity, allowing the transcription of late differentiation
genes.
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Introduction
During somatic tissue differentiation, progenitor proliferating cells
establish a specific programme of gene activation and silencing that
underlies their differentiation into specialized cell types. This
process is nicely recapitulated during epidermis formation and
epidermis homeostasis. Recent studies demonstrated that epigenetic
regulators from multiple classes play a critical role in activating and
repressing gene expression by affecting the chromatin state. The
epigenetic regulators that promote proliferation and inhibit activa-
tion of terminal differentiation-associated genes in progenitor cells
include DNA methyltransferase 1 (DNMT1) [1], histone deacety-
lases 1 and 2 (HDAC1/2) [2], and polycomp components Bmi1,
Ezh1/2 [3–5] and Cbx4 [6]. Conversely, histone demethylase
Jumonji domain-containing 3 [7], adenosine triphosphate-depen-
dent (ATP-dependent) chromatin remodeller Brg1/BAF complex
[6,8,9] and genome organizer Satb1 [10] promote terminal keratino-
cyte differentiation [11–15]. The BAF pro-differentiation role is
prevented by ACTL6A (actin-like 6A, also known as BAF53A), a
BAF-associated protein that is highly expressed in proliferating
epithelial precursors [8]. However, the mechanism through which
ACTL6A inhibits DNA targeting of the BAF complex is not known,
nor is the mechanism to drive ACTL6A down-regulation/inactiva-
tion in epithelial progenitors to allow differentiation.
In the last decade, long non-coding RNAs (lncRNAs) have gener-
ated significant interest in controlling progenitor stem cell biology
and somatic lineage specification and differentiation [16,17]. So far,
only few lncRNAs have been described to play a role in controlling
the proliferation/differentiation switch in keratinocytes: ANCR, anti-
differentiation ncRNA, and TINCR, terminal differentiation-induced
ncRNA. Although TINCR controls differentiation via a post-tran-
scriptional mechanism, the ANCR-mediated mechanism to promote
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the undifferentiated cell state in the epidermis has not been identi-
fied [18,19]. Similarly, LIN00941 has also been recently implicated
in controlling epidermal homeostasis repressing the expression of
pro-differentiation genes with an not-yet identified mechanisms
[20]. Through a bioinformatics analysis comparing mouse, rat and
human genomes, a specific sub-class of lncRNAs containing ultra-
conserved regions (UCRs) was identified [21–23]. LncRNA-
containing UC regions are transcribed from 481 genomic loci that
contain 200–779 bases of highly conserved sequences amongst the
three species mentioned before [21], with 100% identity (no inser-
tions or deletions). Interestingly, under genomic instability condi-
tions such as cancer, these UC sequences accumulate mutations
[24]. A large fraction of these 481 genomic loci are transcribed (T-
UCRs) in normal cells and tissues; some of them are ubiquitously
expressed, whereas others follow tissue-specific expression patterns
[25–29]. T-UCR functions are largely unknown; the fact that they
contain a highly conserved region implies that they are important
for mammalian phylogenesis and/or ontogenesis [21].
Here, starting from a genome-wide expression profiling, we
demonstrated for the first time a functional link between UC-
containing lncRNAs (T-UCRs) and the switch between the undif-
ferentiated state and the terminal-differentiated state in the epider-
mis. We found that uc.291 physically interacts with ACTL6A
modulating chromatin remodelling to allow differentiation. Chro-
matin immunoprecipitation (ChIP) experiments show that silencing
uc.291 preserves the ACTL6A binding to differentiation gene
promoters and possibly inhibits the BAF complex from targeting
epidermal differentiation complex (EDC) genes; conversely, in the
presence of uc.291, ACTL6A is released, allowing chromatin
changes to promote the expression of epithelial differentiation
genes.
Results
Uc.291 expression changes during epidermal differentiation
To investigate the role of UC-containing lncRNAs (T-UCRs) in
progenitor/undifferentiated and differentiated keratinocytes
(HEKn, human epidermal keratinocytes, neonatal), we performed
a microarray in which we compared T-UCR expression profiles of
undifferentiated proliferating keratinocytes with those of differenti-
ated keratinocytes (Fig 1A). We found 79 T-UCRs that are signifi-
cantly modulated during the differentiation (P < 0.05, 22 up-
regulated; 57 down-regulated) (Fig EV1A; Appendix Table S1).
After RT–qPCR validation of 20 T-UCRs (Fig EV1B and C), we
selected uc.291 (fold change 3.8  0.9) for functional studies,
taking into account that uc.291 was consistently up-regulated
during keratinocyte differentiation also in different human kerati-
nocyte donors (Fig 1B); it has also been detected in many human
epithelial tissues [25]. Uc.291 gradually accumulates during HEKn
calcium-induced differentiation, increasing by 2.2-, 7.5- and 8.5-
fold over the control after 3, 6 and 9 days of treatment, respec-
tively (P < 0.05, P < 0.01; Fig 1B). Its expression paralleled the
expression of early (IVL, KRT10) and late (LOR) differentiation
markers (Fig 1C). These in vitro results were confirmed by in situ
hybridization of the human epidermis, showing uc.291 accumula-
tion in the epidermis supra-basal layers and a strong staining in
supra-basal nuclei (Fig 1D). HEKn FISH analysis (Fig 1E) and
subcellular fractionation (Fig 1F, fold change 112  29, P < 0.05)
showed that it is mainly found in the nuclei of keratinocytes,
indicating a nuclear function of this pro-differentiation lncRNA.
Notably, the uc.291 transcript has the same orientation of its
hosted gene, and it is expressed approximately eightfold higher
than the antisense transcript (that is the limit of detectability;
Figs 1G and H, and EV2A–C); therefore, siRNAs were designed to
specifically target the sense uc.291 transcript. Uc.291 is located
on chromosome 10 (hg38, chr10:76,523,866–76,524,096) and is
hosted in the sixth intron of the LRMDA gene (previously named
C10orf11, Fig 1H). During keratinocyte differentiation, the expres-
sion of the LRMDA flanking exons (exon 2–3 and exon 6–7) by
RT–qPCR (Fig 1I) decreases, indicating that uc.291 is transcribed
independently from LRMDA mRNA. Originally, only the ultracon-
served sequence (231 bp in Ref. [21]; 424 bp in UCNEbase) of
uc.291 was known (Fig 1H); to gain additional information on
the transcript, we performed a “cDNA walking” approach using
multiple primer amplifications and cloned a transcript of 3,816 nt
(nucleotides) that included the original UCR (Appendix Figs S1
and S2).
Silencing of uc.291 alters epidermal proliferation
and differentiation
The biological function of uc.291 was assessed by RNA interfer-
ence in primary human keratinocytes growing in differentiating
conditions. SiRNA sequence specificity was validated both in
HEKn and in FaDu cancer cells (Fig 1J). FISH experiments
performed after si-uc.291 did not detect signals in contrast to
scramble transfected cells, further confirming siRNAs specificity
for uc.291 (Fig 1K).
Silencing of uc.291 during differentiation strongly impaired this
process. This was evaluated by RT–qPCR (Fig 2A) and by Western
blot (WB) analysis of differentiation genes (Fig 2B). Notably, the
late differentiation marker Loricrin was strongly reduced at both
mRNA and protein levels, while the early differentiation marker
Keratin 10 (K10) was not affected by uc.291 expression (Fig 2B),
thereby suggesting an important role in the late differentiation steps.
Interestingly, uc.291 is a pro-differentiation transcript independently
from the differentiation stimuli used in vitro; beside calcium-
induced differentiation (Figs 1B and EV3A, CaCl2), uc.291 is up-
regulated even with confluence-induced differentiation in both
EpiLife medium and Eagle’s minimum essential medium (Fig EV3A,
Epi and EMEM). Uc.291 knock-down in organotypic human epider-
mal tissue, a setting that recapitulates the structure and the gene
expression profile of the human epidermis [30], confirmed the data
shown thus far. Although the uc.291-deficient epidermis was
normally stratified, the expression of key differentiation genes,
including Loricrin and Filaggrin, was markedly reduced, while K10
did not change (Fig 2C). In uc.291-depleted human organotypic
epidermis, the expression of the proliferation marker Ki67 increased
from 18.9 to 23.1% (P < 0.05) and 24.8% (P < 0.01) in scramble
and si-uc.291 sequences 1 and 2, respectively (Fig EV3B). Similarly,
p63-positive keratinocytes increased from 64.2 to 70.6% (P < 0.05)
and 72.2% (P < 0.01) in the same conditions, respectively (Fig 2D
and E), while we detected a decrease of the cyclin-dependent kinase
inhibitor 1B (p27Kip1) and a higher expression level of DNp63 in
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si-uc.291 cells grown in both proliferating and differentiating condi-
tions (Fig 2F).
Altogether, these results strongly indicate that uc.291 is required
to allow the expression of terminal differentiation genes and that
alteration of the late differentiation steps also affects the proliferat-
ing keratinocyte compartment (Fig 2G).
Silencing of uc.291 disrupts the expression of genes involved in
epidermal differentiation
To gain further information on the role of uc.291 during differentia-
tion, transcriptomic profiling of uc.291-depleted differentiating kera-
tinocytes was performed. We demonstrated that the down-
regulation of uc.291 affected the expression of 596 genes (P < 0.05),
203 of which were up-regulated and 393 were down-regulated
(Fig 3A–C; Dataset EV1). Uc.291-regulated genes were enriched for
skin, epidermis, and epithelia development-, epidermal cell differen-
tiation- and keratinization-related Gene Ontology (GO) terms
(Fig 3D and E). The latter is in line with the phenotype of the
uc.291-depleted epidermis (Fig 2). Interestingly, amongst the down-
regulated genes, 23 belonged to the EDC (Fig 3F and G). The EDC
comprises several genes that are of crucial importance for the matu-
ration/keratinization of the human epidermis and are located in a
2 Mb region on human chromosome 1q21 [31,32]. The EDC
contains three clustered families of genes that encode a group of
precursor proteins of the cornified envelope (CE), including involu-
crin, Loricrin, SPRRs (small proline-rich proteins) and the “late
cornified envelope” (LCE) proteins; calcium-binding proteins
(S100); and the “fused gene” proteins (SFTPs), including Filaggrin,
Filaggrin-2, trichohyalin, trichohyalin-like protein, hornerin, repetin
and cornulin (Fig 3F and G) [33]. RT–qPCR was used to validate the
down-regulation of EDC genes (Fig 3H); we also confirmed their
down-regulation in the uc.291-depleted epidermis (Fig 3I). These
results confirmed that uc.291 is important for regulating gene
expression during differentiation, including the expression of many
genes located in the EDC, including LOR.
Uc.291 interacts with ACTL6A
The effect of uc.291 depletion on the expression of EDC genes
suggested that uc.291 could interfere with epigenetic modulators
that control gene expression during differentiation. To determine
the mechanisms of uc.291 action, we aimed to identify uc.291
binding proteins of relevance to epidermal differentiation. Uc.291
sense and antisense (the latter as control) RNA was transcribed
with Cy5 and independently hybridized to a protein microarray
(HuProt v.2 Human Proteome Arrays) containing 50,000 recombi-
nant human proteins (Fig EV4A and B). We performed two repli-
cates, obtaining a correlation of 0.79 for RNA-binding protein
(RBP) interactions and 0.76 for chromatin-related proteins
(Fig EV4C). Using the fluorescence over background (F-B) average
calculated for both replicates, we selected uc.291 interactions with
a positive score (15,400; Fig EV4B). The filtering computational
procedure narrowed down the list. To investigate the specific link
between uc.291 and chromatin modification, we restricted our
analysis to chromatin-related proteins (QuickGO and UniProt),
resulting in 40 candidates (Appendix Table S2; Fig EV4D), 20 of
which are epidermis-expressed proteins (Fig 4A and B;
Appendix Table S2). We found that ACTL6A is the 3rd ranked
candidate out of 20 proteins, preceded by BATF2 and SMARCE1.
ACTL6A is a BAF-associated protein and is highly expressed in
proliferating epithelial precursors [8]; it was recently shown to
block the BAF pro-differentiation role that specifically affects EDC
gene expression [11,15]. Uc.291 and ACTL6A reciprocal binding
was demonstrated by RNA cross-linking immunoprecipitation
(CLIP) and by RNA immunoprecipitation (RIP) experiments
(Fig 4C and D) using a specific anti-ACTL6A antibody. We added
SMARCC2, another subunit of the complex, and found that it
interacts with uc.291 by CLIP. As negative control, we tested a
nuclear unrelated transcript FAM83-AS1 [8]. FAM83-AS1 is
expressed in both proliferating and differentiating keratinocytes,
and RIP experiment showed a negative result confirming that,
unlike uc.291, FAM83-AS1 does not interact with ACTL6A
◀ Figure 1. Uc.291 expression is induced during epidermal differentiation.A Workflow of the study.
B Relative uc.291 expression quantification during calcium-induced in vitro differentiation of HEKn (3, 6 and 9 days of differentiation, DD). The quantification is relative
to uc.291 expression in proliferating HEKn (0 day). Data shown represent the mean  standard deviation (s.d.); n = 4 different human donors; *P < 0.05, **P < 0.01,
Student’s t-test.
C Involucrin (IVL), Keratin 10 (KRT10) and Loricrin (LOR) expression levels evaluated by RT–qPCR are shown as positive control of differentiation. The quantification is
relative to gene expression in proliferating HEKn (0 day). Data shown represent the mean  s.d.; n = 3 technical on 1 of the 4 human donors used in panel (B);
*P < 0.05, Student’s t-test.
D Haematoxylin/eosin (H&E) staining and in situ hybridization of specific (uc.291) or not specific (negative control, NC) probes on human skin section. Scale bars denote
50 and 500 lm.
E RNA FISH for uc.291 (red, Quasar 570) on HEKn at 9 days of differentiation. Nuclei were stained with DAPI. Scale bar: 10 lm.
F Relative uc.291 quantification after RNA isolation from cytosolic and nuclear cellular compartments. snRNA U6 quantification was used as nuclear fraction positive
control, while ACTB as cytosolic fraction positive control. Data shown are mean  s.d.; n = 3 technical on 1 of the 4 human donors used in panel (B); *P < 0.05,
**P < 0.01, Student’s t-test.
G Strand-specific RT–qPCR shows that uc.291 is transcribed in genomic sense orientation in HEKn cells; n = 2 technical (#1 and #2) on 1 human donor; SS: sense
strand transcript, AS: antisense strand transcript.
H Picture showing uc.291 and LRMDA genomic location.
I Expression of uc.291 and LRMDA exons 2-3 and exons 6–7 during keratinocyte differentiation. Data shown are mean  s.d.; n = 2 different donors (3 technical/donor);
*P < 0.05, **P < 0.01, Student’s t-test.
J Relative uc.291 quantification after si-uc.291(1) and si-uc.291(2) in HEKn and FaDu cells. Data shown are mean  s.d.; HEKn n = 3 technical on 1 human donor; FaDu
n = 2 biological replicates (3 technical/biological replicate); *P < 0.05, Student’s t-test.
K RNA FISH for uc.291 (red, Quasar 570) on A253 in scramble (SCR) and silenced (si-uc.291(1) and si-uc.291(2)) cells. Nuclei were stained with DAPI. Scale bar: 10 lM.
The histogram derives from the RT–qPCR using the leftover cells after removing the slides used for the FISH staining. Data shown are mean  s.d; n = 3 biological
replicates *P < 0.05, Student’s t-test.
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(Fig EV5A and B). The predicted uc.291 region interacting with
ACTL6A (score = 0.59, prediction by Global Score [34]) results in
a highly structured region as shown by the CROSS algorithm
modelling [35] (Fig 4E and F; Appendix Fig S2). Our results indi-
cate that uc.291 interacts with ACTL6A to modulate chromatin
remodelling.
Silencing of uc.291 affects the chromatin status of Loricrin,
Filaggrin and LCE1B promoters
To demonstrate that uc.291 and ACTL6A interaction has a func-
tional role in controlling the expression of differentiation genes,
we performed a chromatin immunoprecipitation (ChIP) assay on
selected differentiation gene promoters (LOR, FLG and LCE1B) that
were down-regulated upon uc.291 silencing (Figs 2 and 3), to
examine ACTL6A and BRM/BRG1 binding as a function of uc.291.
We confirmed that in proliferating conditions, ACTL6A binds LOR,
FLG and LCE1B promoters to block the binding of BRM/BRG1,
which are the BAF catalytic subunits [8] (Fig 5A). This is in line
with previous results showing that BRM/BRG1 (BAF complex) are
required to bind and activate differentiation gene promoters. This
binding is repressed by ACTL6A in progenitors and proliferating
keratinocytes [8,9]. Instead, differentiated keratinocytes displayed
enhanced binding of BRM/BRG1 at the promoter of the selected
genes, whereas ACTL6A did not bind them (Fig 5B, SCR). BRM/
BRG1 binding paralleled the H3K27ac histone modification and
LOR, FLG and LCE1B expression at the mRNA levels (Fig 5C and
D). Interestingly, the depletion of uc.291 in differentiating condi-
tions resulted in enhanced ACTL6A binding and reduced BRM/
BRG1 binding (Fig 5B, si-uc.291). Consequently, we detected a
decrease of histone modification in H3K27ac (Fig 5D) and the
decreased expression of LOR, FLG and LCE1B at the mRNA levels
and LOR at the protein level (Fig 5C and E). Controls for an
uc.291-unrelated gene (TATA-box-binding protein, TBP) are shown
in Fig EV5C. The role of ACTL6A in repressing differentiation gene
expression is confirmed in Fig 5C and D, in which the depletion of
ACTL6A resulted in increased LOR, FLG and LCE1B at the mRNA
levels and LOR at the protein level. To note that uc.291 silencing
does not affect ACTL6A expression and that ACTL6A and uc.291
are partially co-expressed as indicated in in vivo calcium-induced
differentiation and in organotypic human epidermis (Appendix Fig
S3A and B). Altogether, these results indicate that uc.291, by inter-
fering with ACTL6A, participates in the release of ACTL6A inhibi-
tory effects on the BAF complex, thus allowing it to bind to and
activate differentiated genes. To further confirm our findings, we
compared transcript profiling between ACTL6A- and si-uc.291-defi-
cient keratinocytes (Fig 6A). We found that transcript profiling of
ACTL6A-deficient keratinocytes [8] showed an overlap with uc.291
regulated genes (39 genes). In particular, we found that the genes
repressed by ACTL6A in proliferating keratinocytes are also down-
regulated by si-uc.291 in differentiating conditions, further support-
ing the observation that the interaction between uc.291 and
ACTL6A is required to allow the expression of epidermal differenti-
ation genes.
◀ Figure 2. Silencing of Uc.291 affects epidermal differentiation.A Relative quantification of the differentiation markers LOR and IVL in HEKn transfected with uc.291 siRNA (1) and (2) or SCR control siRNA and collected after 3 days of
differentiation. Data shown represent the mean  s.d.; n = 4 different human donors; **P < 0.01, Student’s t-test.
B WB showing DNp63a, Klf4, K10 and Loricrin (LOR) protein levels in HEKn transfected cells as described in (A). b-actin was shown as loading control. One
representative experiment of three is shown.
C IF staining of late differentiation markers Loricrin and Filaggrin in uc.291-depleted, si-uc.291(1) and si-uc.291(2), organotypic human epidermis compared to scramble
control one (SCR); haematoxylin/eosin (H&E) staining shows the organotypic epidermis structure (left panels); scale bars: 50 lm. The magnified boxes show
expression of Loricrin and Filaggrin in the granular layer; scale bars: 10 lm. Dotted lines represent the insert border. One representative experiment of three is shown.
D IF staining and confocal analysis of p63 in the organotypic human epidermis obtained as described in (C). Dotted lines represent the insert border. One representative
experiment of three is shown. Scale bars: 50lm.
E Box plot showing quantification of p63-positive nuclei on total nuclei. Each central line represents the median; each box represents Q1 (quartile 1, below the median)
and Q3 (quartile 3, above the median); the whiskers represent minimum (Q1  1.5*IQR) and maximum (Q3 + 1.5*IQR). IQR = interquartile range; 16, 15 and 19 images
were analysed for SCR, si-uc.291 (1) and si-uc.291 (2) respectively; *P < 0.05; **P < 0.01, Student’s t-test.
F WB showing cyclin-dependent kinase inhibitor 1B (p27Kip1) and DNp63a protein levels in HEKn cells transfected with uc.291 siRNA (2) or SCR control siRNA and
collected in proliferating (0 day) or differentiating (1, 2 and 3 days of differentiation, DD) conditions. b-actin was used as loading control. The numbers below the
bands represent the densitometric analysis normalized for the loading control. One representative experiment of three is shown.
G Schematic representation of the expression of selected markers in organotypic human epidermis upon uc.291 depletion.
Source data are available online for this figure.
▸Figure 3. Uc.291 regulates the expression of epidermal differentiation genes, including the epidermal differentiation complex (EDC) genes.A Heatmap showing gene expression profile of HEKn silenced by either SCR or si-uc.291 (2) siRNAs by gene microarray analysis; n = 4 technical replicates using 1
human donor; P < 0.05, Student’s t-test, abs (FC) > 2.
B RT–qPCR confirming the efficiency of silencing. Data shown are mean  s.d; the same samples of (A) were used; **P < 0.01, Student’s t-test.
C Volcano plot showing fold changes of differently expressed genes from (A): up-regulated genes are shown in red, and down-regulated genes are shown in dark grey.
D GO terms analysis for genes down-regulated upon uc.291 depletion from (A).
E GSEA comparing a query gene set of modulated genes from (A) with GO biological process signatures associated with epidermis development and keratinocyte
differentiation. NES = normalized enrichment score, FDR = false discovery rate. Kolmogorov–Smirnov statistic was used.
F Heatmap showing gene expression of the most down-regulated genes located within epidermal differential complex (EDC) upon depletion of uc.291 from (A).
G Scheme of the epidermal differentiation complex (EDC) genes.
H Validation of array data by RT–qPCR showing mRNA quantification of thirteen EDC genes down-regulated upon si-uc.291. Data shown are mean  s.d.; (n = 3
different human donors); **P < 0.01, Student’s t-test).
I Validation of array data by RT–qPCR showing mRNA quantification of eight EDC genes down-regulated in uc.291-depleted organotypic human epidermis; n = 2
technical (#1 and #2) from 1 human donor.
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Figure 4. Uc.291 interacts with ACTL6A.
A Network of putative interactors, ranked as described in the text, and relative GO analysis. Interactors expressed in the epidermis are shown; see also
Appendix Table S1.
B GO analysis of the predicted interactors.
C RT–qPCR showing the validation of uc.291-ACTL6A interaction by RNA cross-linking immunoprecipitation (CLIP) in HEK293E cells, as fold enrichment over IgG.
SMARCC2 was also included. Data shown are mean  s.d.; n = 3 (technical); *P < 0.05, Student’s t-test. On the right, control WB for immunoprecipitation of both
antibodies.
D RT–qPCR showing the validation of uc.291-ACTL6A interaction by RNA immunoprecipitation (RIP) in differentiated HEKn as fold enrichment over IgG. Data shown are
mean  s.d.; n = 3 technical, on 1 human donor; *P < 0.05, Student’s t-test. On the right, control WB for immunoprecipitation.
E Secondary structure of uc.291 predicted binding region (nt 1,700–2,000) using the CROSS Global Score as a soft constraint inside RNA structure [43].
F Uc.291 predicted binding region to interact with ACTL6A (nucleotide 1,763–1,912) by Global Score (score of 0.59). Dotted line defines the CROSS score threshold [43].
Source data are available online for this figure.
8 of 14 EMBO reports e46734 | 2020 ª 2020 The Authors
EMBO reports Emanuele Panatta et al
AB
C
D E
Figure 5. Uc.291-ACTL6A interaction modifies chromatin status at LOR, FLG and LCE1B promoters.
A Agarose gel electrophoresis of LOR, FLG and LCE1B promoter fragments amplified by end-point PCR after ACTL6A and BRM (left), or BRG1 (right) chromatin IP in
proliferating keratinocytes.
B Agarose gel electrophoresis of the same PCR products described in (A) after ACTL6A (left), BRM (middle) and BRG1 (right) chromatin IP in uc.291 silenced and
differentiated HEKn cells. One representative experiment of three is shown.
C Relative quantification by RT–qPCR of LOR, FLG and LCE1B mRNA in uc.291 and ACTL6A silenced and differentiated HEKn cells. Data shown are mean  s.d.; n = 3
(technical); *P < 0.05, Student’s t-test.
D Quantification by real-time PCR of LOR, FLG and LCE1B promoter fragments after H3K27ac chromatin IP in the same samples described in (B). Data shown are
mean  s.d.; n = 3 (technical); *P < 0.05, Student’s t-test.
E WB analysis of Loricrin expression in uc.291 and ACTL6A silenced and differentiated HEKn cells. b-actin was used as loading control. One representative experiment of
three is shown.
Source data are available online for this figure.
ª 2020 The Authors EMBO reports e46734 | 2020 9 of 14
Emanuele Panatta et al EMBO reports
Discussion
Many studies have indicated a critical role of chromatin regula-
tors in controlling somatic stem cell fate and epithelial differentia-
tion [2–6,8]. Amongst them, the BAF (SWI/SNF, switch/sucrose
non-fermenting) complex has been shown to have a crucial role
for proper execution of the epidermal differentiation programme,
in which it regulates the transition from the epidermal progenitor
state (proliferating basal layer keratinocytes) to the epidermal dif-
ferentiated state (spinous, granular and cornified layers keratino-
cytes) [9,11]. Recently, ACTL6A, which is a part of several
epigenetic regulator complexes [36], has been shown to play a
crucial role in modulating the BAF complex to block keratinocyte
differentiation [8]. ACTL6A prevents the BAF complex from bind-
ing to promoters of differentiation genes [37]. Indeed, in vivo
ablation of ACTL6A resulted in decreased proliferation, acceler-
ated differentiation and skin hypoplasia, whereas over-expression
resulted in the expansion of the proliferation compartment.
ACTL6A is also amplified and highly expressed together with
DNp63; it is physically associated with DNp63 in squamous cell
carcinomas of the head and neck [38–42]. This opens up an
unexplored possibility that uc.291 could also play a role in head
and neck squamous cell carcinomas. Many aspects regarding
ACTL6A-BAF complex regulation remain unknown, including the
mechanistic action that the actin-like proteins employed on the
BAF complexes and how ACTL6A inhibits/interferes with DNA
targeting of the BAF complex in proliferating/progenitor cells; our
data provide some interesting light. Here, we identified a novel
mechanism involving a long non-coding RNA that contains an
ultraconserved element, named uc.291. Uc.291 participates in the
establishment of cell-specific epigenetic changes. Its expression
increases during differentiation; by physically interacting with
ACTL6A, it releases the ACTL6A-mediated repression of differenti-
ation genes (Fig 6B). Following uc.291-ACTL6A interaction, the
BRM/BRG1 subunit (BAF complex) is able to interact with dif-
ferentiation promoters and releases chromatin to allow the tran-
scription of EDC genes (Fig 6B). Interestingly, in addition to
ACTL6A, amongst the putative uc.291 interactors, we identified
other chromatin-related subunits belonging to the BAF (SWI/SNF)
complex, such as SMARCE1 (chromatin remodelling complex
BRG1-associated factor 57), SMARCC2 (BAF170 or mammalian
chromatin remodelling complex BRG1-associated factor 170) and
SMARCD3 (BAF60C or SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily D member 3). Beside
ACTL6A, we validated uc.291-SMARCC2 interaction by CLIP, yet
we do not have evidences that this is a direct interaction. These
findings further support that amongst the chromatin-associated
epigenetic modulators, uc.291 is strongly associated with ATP-
dependent nucleosome remodelling complexes. However, other
chromatin modulators, i.e. BMI1 (component of the polycomb
group complex 1) and SIRT1 (NAD-dependent protein deacety-
lase), are also putative interactors. The protein microarray also
shows that transcription factors and transcription co-activators
including BATF2, GATA2, GATA3 and CRTC2 interact with
uc.291 with a high score (Appendix Table S2). Altogether, these
results suggest that uc.291 may be involved in gene expression
regulation with additional mechanisms, yet to be identified. An
intriguing issue is the function of the ultraconserved sequence
contained in uc.291 (nt 717–1,140). We modelled the secondary
structure of this region using CROSS [35] and found that is highly
structured. Amongst the 40 interactors identified, none have been
predicted to interact with this region, opening new interesting
scenarios leading to the investigation of other possible functions.
Altogether, our results describe a human terminal differentiation-
associated lncRNA that interacts with an ATP-dependent nucleo-
some remodelling complex subunit to exert a non-redundant role in
controlling somatic differentiation and tissue homeostasis. Our
study expands the understanding of the complexity of the epigenetic
regulation that occurs during epithelial differentiation, necessary to
balance progenitor compartment and terminally differentiated cells.
Materials and Methods
Cell culture and transfection
Human epidermal keratinocytes, neonatal (HEKn) (Cascade,
Invitrogen) were grown in EpiLife medium supplemented with
HKGS (Invitrogen). Differentiation was induced by 1.2 mM
A
B
Figure 6. Uc.291 and ACTL6A regulate common genes.
A Venn diagram showing the uc.291 up-regulated genes in si-uc.291
keratinocytes in common with the si-ACTL6A down-regulated genes. The 39
common genes are listed below, and the EDC genes are indicated. The
expression of the genes is inversely correlated. The inverse correlation
amongst them functionally supports the negative regulation of uc.291 in
controlling ACTL6A functions.
B Schematic model of uc.291 role in regulating epidermal differentiation.
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CaCl2 addiction to culture medium. HEKn were transfected
using two different si-uc.291 sequences. HEKn were transfected
using two different si-uc.291 sequences HP Custom siRNA (Qia-
gen) or a negative control siRNA (Qiagen) by Lipofectamine
RNAiMAX reagent (Invitrogen) according to the manufacturer’s
protocols. Forty-eight hours after transfection, in vitro differenti-
ation was induced. Specific uc.291 siRNA sequences are as
follows: si-uc.291 (i) 50-GUAUUGAUUAAACUUUUAAAUTT-30
and si-uc.291 (ii) 50-ACAGG CUGAGAACAGAUTT-30. HEK293E
cells were grown in Dulbecco’s modified Eagle’s medium
(Thermo Fisher) supplemented with 10% (vol/vol) foetal
bovine serum (Thermo Fisher) and 1% penicillin/streptomycin
(Thermo Fisher). HEK293E cells were transfected to express
full-length TUC-291 lncRNA using Effectene Reagent (Qiagen)
according to the manufacturer protocol. FaDu and A253 cells
were grown, respectively, in Eagle’s minimum essential medium
and McCoy’s 5A medium supplemented with 10% (vol/vol)
foetal bovine serum and 1% penicillin/streptomycin. FaDu and
A253 were transfected using two different si-uc.291 sequences
HP Custom siRNA (Qiagen) or a negative control siRNA (Qia-
gen) by Lipofectamine RNAiMAX reagent (Invitrogen) according
to the manufacturer’s protocols.
Cell fractionation and RNA extraction
Cells were resuspended in 1 ml of RSB (10 mM Tris, pH 7.4, 10 mM
NaCl, 3 mM MgCl2), incubated for 3 min on ice and centrifuged at
4°C. Cell pellet was resuspended in four volumes of lysis buffer
RSBG40 (10 mM Tris, pH 7.4, 10 mM NaCl, 3 mM MgCl2, 10% glyc-
erol, 0.5% Nonidet P-40, 0.5 mM DTT and 100 U/ml rRNasin
Promega, WI). Nuclei were pelleted by centrifugation at 4,600 g for
3 min, and the supernatant was saved as the cytoplasmic fraction.
Nuclear pellets were resuspended in RSBG40, and one-tenth volume
of detergent buffer was added (3.3% wt/wt sodium deoxycholate
and 6.6% vol/vol Tween 40). Nuclei were incubated 5 min on ice
and pelleted. Supernatant was saved and added to cytoplasmic frac-
tion. Nuclei were collected by centrifugation at 9,400 g for 5 min,
and the resulting pellet was used for nuclear RNA extraction. RNA
was extracted using TRIzol method, according to the manufacturer’s
instructions (Invitrogen, CA). Cell lysis and nuclear integrity were
monitored during the procedure by light microscopy following
trypan blue staining.
Gene array
Total RNA was extracted with mirVana miRNA isolation kit
(Ambion, AM1561). RNA quality was monitored by Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA). Cyanine-3
(Cy3)-labelled cRNA was prepared from 100 ng RNA using the Low
Input Quick Amp Labeling Kit one-colour (Agilent) according to the
manufacturer’s instructions and purified by RNeasy column
(QIAGEN, Valencia, CA). Dye incorporation and cRNA yield were
checked with the NanoDrop ND-1000 Spectrophotometer. 600 ng of
Cy3-labelled cRNA (specific activity > 6.0 pmol Cy3/lg cRNA) was
fragmented at 60°C for 30 min following the manufacturer’s instruc-
tions and then hybridized to Agilent SurePrint G3 Human 8 × 60k
Microarrays (G4858A) for 17 h at 65°C. Slides were washed and
dried. Slides were scanned by Agilent DNA Microarray Scanner
(G2505B) using one-colour scan setting (scan area 61 × 21.6 mm,
scan resolution 10 lm, dye channel is set to green and green PMT is
set to 100%). The scanned images were analysed with Feature
Extraction Software 10.3.7.1 (Agilent) using default parameters (pro-
tocol GE1_107_Sep09 and Grid: 039494_D_F_20150612) to obtain
background subtracted and spatially detrended Processed Signal
intensities. Features flagged in Feature Extraction as feature non-
uniform outliers were excluded. Microarray data have been depos-
ited in the NCBI’s Gene Expression Omnibus [GEO: GSE103890].
cDNA walking
Two lg of total RNA from differentiated HEKn was retrotranscribed
as described before to obtain cDNA. PCR was performed using
Phusion High-Fidelity DNA Polymerase (Thermo Scientific) accord-
ing to the manufacturer’s protocol, and the PCR fragments of inter-
est were completely sequenced. The primers used are listed in
Appendix Table S3.
Organotypic epidermis culture
After 48-h transfection, 3 × 105 HEKn cells were resuspended in
CnT-PR medium (CELLnTEC) and seeded onto Millicell PCF 12 mm
inserts with 0.4 lm pore size (PIHP01250; Millipore). Twenty-four
hours later, medium was replaced inside and outside the insert with
CnT-PR-3D medium (CELLnTEC). Twenty-four hours later, air-
lifting was induced by removing the medium inside. Outside,
medium was changed every 3 days during the following of 20 days
of culture. Inserts were fixed in 10% buffered formalin solution,
processed and paraffin-embedded.
In situ hybridization
Human tissues were embedded in frozen specimen medium Killik
(Bio-Optica) after an overnight incubation in 4% paraformaldehyde
followed by an overnight incubation in 0.5 M sucrose. 14-lm-thin
sections were cut and mounted on Superfrost glass slides. Slides
were then fixed for 10 min in 4% paraformaldehyde and acetylated
for 10 min in triethanolamine/acetic anhydride. Slides were then
hybridized in incubation chambers overnight at 46°C using 30 nM
detection digoxigenin probes (miRCURY LNA; Exiqon). After
hybridization, slides were washed (20 min in 5 × SSC, two times
for 30 min in Tween 20/SSC at 50°C, and twice for 15 min in
0.2 × SSC and 15 min in PBS at room temperature (RT)). After 1-h
incubation in blocking solution at RT, slides were hybridized for 2 h
in alkaline phosphatase-conjugated antidigoxigenin Fab fragment
(1:200 dilution; Roche, 11093274910) at RT. After two washes of
20 min, detection was performed by incubating 250 ll nitroblue
tetrazolium/BCIP (1-STEP; Thermo Fisher Scientific) together with
2 mM levamisole on the slides for 16 h in the dark at RT.
RNA FISH
Custom Stellaris FISH Probes were designed against Uc. 291
sequence by utilizing the Stellaris RNA FISH Probe Designer
(Biosearch Technologies, Inc., Petaluma, CA) available online at
www.biosearchtech.com/stellarisdesigner. The fixed HEKn cells
were hybridized with the Uc.291 Stellaris RNA FISH Probe set
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labelled with Quasar 570 dye (Biosearch Technologies, Inc.), follow-
ing the manufacturer’s instructions available online at www.biosea
rchtech.com/stellarisprotocols.
Immunofluorescence
Slides were incubated at 60°C for 1 h and dewaxed by Bio-Clear
washing (Bio-Optica) and sections rehydrated by 100, 90, 80, 70 and
50% ethanol incubations. Antigen retrieval was performed by boil-
ing in 0.01 M Sodium Citrate Buffer pH 6.0. IF staining was as
follows: permeabilization by Triton X-100 0.2% PBS incubation; 1-h
blocking in 5% goat serum (Gibco) in PBS at RT; 3-h primary anti-
body incubation at RT; and 1-h secondary antibody and DAPI (40,6-
diamidino-2-phenylindole) incubation at RT. IF images were
acquired by Nikon A1 confocal laser microscope. The following
antibodies were used: anti-K14 (Abcam, ab7800); anti-K14 (BioLe-
gend, PRB-155P); anti-FLG (Santa Cruz, SC66192); anti-LOR (BioLe-
gend, PRB-145P); anti-Ki67 (Cell Signaling, D3B5, 9129S); anti-p63
(Abcam, ab735); Alexa Fluor goat anti-rabbit 568 (Life Technolo-
gies, A11011); goat anti-rabbit 488 (Life Technologies, A11034);
goat anti-mouse 568 (Life Technologies, A11019); and goat anti-
mouse 488 (Life Technologies, A11017).
Haematoxylin/eosin staining
Sections were dewaxed and rehydrated as described before, then
incubated 5 min in Mayer’s haematoxylin (Bio-Optica) solution,
extensively washed in distilled water, incubated 5 min in Eosin Y
alcoholic solution (Bio-Optica), extensively washed in distilled
water and finally dehydrated by 70, 90, 100% ethanol solution incu-
bation. Slides were mounted using Bio Mount HM (Bio-Optica).
Protein microarray
Uc.291 (3,816 nucleotide sequence) sequence was cloned in pBSII-
SK containing T7 promoter using the following primers: 50-GGCCG
CGGCCGCCCTGGGC ACTTAGCTCTCCAC-30 and 50-GGCCCTCGAGC
TTTACGTTTTAGGGTACACGTG-30. The plasmid was linearized and
purified with the MinElute PCR Purification Kit (Beckman Coulter)
following the manufacturer’s instructions. In vitro transcription was
performed with the T7 Megascript T7, High Yield Transcription Kit
(Thermo Scientific) according to the standard procedure with the
addition of 1% DMSO and 1% RiboLock, overnight at 37°C. The
synthetized RNA was treated with TURBO DNAse 2 U/ll (Invitro-
gen) at 37°C for 15 min, purified using magnetic beads (Agencourt
RNAClean XP) and eluted in nuclease-free water. The integrity and
specificity of the RNA were checked by RNA denaturing agarose gel
and Bioanalyzer quality control. Uc.291 was labelled with Cy5 Label
IT uArray Labeling Kit (Mirus). Briefly, 5 lg of RNA was mixed with
1:5 Label IT Cy5 reagent and incubated at 37°C for 70 min. The
labelled RNA was purified by magnetic beads (Agencourt RNAClean
XP). RNA concentration and labelling density were measured using a
NanoDrop 1000 Spectrophotometer (Thermo Scientific) and calcu-
lated as follows:
Base:dye = (Abase*e dye)/(Adye*e base)
Abase = A260-(Adye*CF260)
Constants: e dye = 250,000; CF260 = 0.05; e base = 8,250.
Only reactions with a labelling density of 1 Cy5 dye/700–900nt
were used in the following experiments. Labelled RNA integrity was
verified with the Agilent 2100 Bioanalyzer. Fifty pmol of labelled
RNA was hybridized in the protein arrays HuProt v.2 Human
Proteome Arrays (Cambridge Arrays, LTD). Two technical replicates
were performed. The arrays were dried and immediately scanned at
635 nm in Microarray Scanner G2505B (Agilent). GenePix Pro 6.1
software (Molecular Devices) was used to determine the signal at
635 nm of each spotted protein location and therefore quantify the
RNA-protein interaction. Specifically, the local background intensity
(B635) was subtracted from the intensity (F635) at each of the dupli-
cate spots for a given protein, to quantify. Data were filtered based
on signal to background ratio for each of the duplicate feature to be
greater than 2.5-fold and Z-Score ≥ 3 from the global mean signal
from all the spotted proteins. Finally, the intersection of technical
replicates was considered as the final value for quantification.
Chromatin immunoprecipitation
ChIP was performed using MAGnify Chromatin Immunoprecipita-
tion System (Invitrogen) following the manufacturer’s protocol.
Chromatin was sonicated at 25% amplitude for 15 min (20″ sonica-
tion/30″ pause) using SONOPULS UW3100 (BANDELIN electron-
ics). End-point PCRs were performed using GoTaq G2 Flexi DNA
Polymerase (Promega) according to the manufacturer’s protocol.
Real-time PCR (Fig 5C) was performed using GoTaq qPCR Master
Mix (Promega); the primers used are listed in Appendix Table S5.
The antibodies used were as follows: anti-ACTL6A (Cell Signaling,
76682S); anti-SMARCC2 (Cell Signaling, D809V, 12760S); and anti-
H3K27ac (Diagenode, C15410174).
RNA immunoprecipitation
RIP was performed using Magna RIP RNA-Binding Protein Immuno-
precipitation Kit (Millipore) according to the manufacturer’s proto-
col. RNA (80 ng) was retrotranscribed using SuperScript VILO
cDNA Synthesis Kit (Applied Biosystems) following the manufac-
turer’s protocol. RT–qPCR was performed as described before. The
antibodies used were as follows: anti-ACTL6A (Cell Signaling,
76682S) and anti-SMARC2 (Cell Signaling, D809V, 12760S). RNA/
ChIP was performed using RNA ChIP-IT Kit (Active Motif) according
to the manufacturer’s protocol. RNA was retrotranscribed using
GoScript Reverse Transcription System (Promega) according to the
manufacturer’s protocols. RT–qPCR was performed as described
before. The antibodies used were as follows: anti-ACTL6A (Cell
Signaling, 76682S) and anti-SMARCC2 (Cell Signaling, D809V,
12760S).
RNA extraction and RT–qPCR analysis
Total RNA was isolated from HEKn by RNeasy Mini Kit (QIAGEN)
and retrotranscribed by GoScript Reverse Transcription System
(Promega) according to the manufacturer’s protocols. RT–qPCR was
performed using GoTaq qPCR Master Mix (Promega). The primers
used are listed in Appendix Table S4. The expression of each gene
was defined from the threshold cycle (Ct), and the relative expres-
sion levels were calculated by using the 2DDCt method after normal-
ization with reference to expression of housekeeping gene.
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Strand-specific retrotranscription was performed using GoScript
Reverse Transcription System (Promega). Two reverse transcription
reaction mix were made for strand-specific cDNA synthesis: one to
detect uc.291 sense-oriented transcript (using the following reverse
primer, 50-AGTTGTTCCTAGTAAACCATTTTAC-30 and a reverse
primer for ACTB, 50-AATGTCACGCACGATTTCCCG-30) and one to
detect uc.291 antisense-oriented transcript (using the following
forward primer, 50-GGATGA AAAGATGGTGGACAAAC-30 and the
same reverse primer for ACTB). qPCR was carried on by TaqMan
probe using the following primers/probe: uc.291FW 50-TTT
GTGAGCCCCGCATTC-30; uc.291 REV 50-AATGACACGTCAGCCGT
CTTT-30; and uc.291 probe, 50-ACTTTCCTTTGAGGTTGGT-30.
Western blot
Total cell extracts were resolved on a SDS–polyacrylamide gel and
blotted on Amersham Hybond P0.45 PVDF membrane (GE Healthcare
Life Science). Membranes were blocked by non-fat dry milk Blotting-
Grade Blocker (Bio-Rad) 5% in PBS 0.1% Tween-20 (Sigma-Aldrich),
incubated with primary antibodies overnight at 4°C, washed and
hybridized for 1 h at RT using the appropriate secondary antibody.
The following antibodies were used: anti-p27 (BD Biosciences,
610241); anti-p63 (Abcam, ab735); anti-p63a (Cell Signaling,
CS13109); anti-KLF4 (R&D System, 12173S); anti-K10 (BioLegend,
PRB-159P); anti-LOR (BioLegend, PRB-145P); anti-b-actin AC-15
(Sigma, A5441); goat anti-mouse HRP Conjugate (Bio-Rad, 170-5047);
goat anti-rabbit HRP Conjugate (Bio-Rad, 170-6517); and bovine anti-
goat HRP conjugate (Santa Cruz Biotechnology, SC-2350).
Bioinformatics and statistics
The biological process categories were obtained by using Gene
Ontology Consortium tools (www.geneontology.org/). Experimental
result significance was evaluated by Student’s t-test as expression of
P-value (*P < 0.05; **P < 0.01).
Data availability
The data reported in this paper have been deposited in GEO:
GSE103890 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE103890).
Expanded View for this article is available online.
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Expanded View Figures
A
B C
Figure EV1. UC RNA is modulated during keratinocyte differentiation.
A Heatmap showing microarray data results. Data are expressed as fold change.
B Validation by RT–qPCR of down-regulated UCs showed in (A).
C Validation by RT–qPCR of up-regulated UCs showed in (A). In (B) and (C), the quantification is relative to the same UC expression in undifferentiated HEKn (undiff.,
dark grey bars); data shown represent the mean  standard error (RT–qPCR has been done in triplicate); n = 1 (technical).
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Figure EV2. Characterization of uc.291 transcript by strand-specific RT–qPCR.
A Uc.291 (3,816 bp) genomic location on chromosome 10 in the sixth intron of the C10orf11 gene.
B Uc.291 strand-specific RT–qPCR; representative amplification plots (#2 of Fig 1G) of strand-specific RT–qPCR; qPCR curves relative to the sense and the antisense
transcripts are shown.
C ACTB mRNA strand-specific RT–qPCR was used as control.
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Figure EV3. uc.291 is up-regulated during keratinocyte differentiation, regardless of the differentiation methodology.
A RT–qPCR showing uc.291 expression in HEKn grown in calcium-induced differentiation (CaCl2) or confluence-induced differentiation (in Epi and EMEM).
CaCl2 = calcium chloride; Epi = EpiLife; EMEM = Eagle’s minimum essential medium. LOR, KRT10 and LCE1B were used as differentiation markers. DD = days of
differentiation; the quantification is relative to the same expression in undifferentiated HEKn (0 DD); data shown represent the mean  standard deviation; n = 3
(technical); *P < 0.05, **P < 0.01, Student’s t-test.
B Box plot showing quantification of Ki67-positive nuclei on total nuclei. In parallel with the increase of p63 expression (Fig 2), depletion of uc.291 affects the
proliferation rate of basal keratinocytes. Each central line represents the median; each box represents Q1 (quartile 1, below the median) and Q3 (quartile 3, above the
median); the whiskers represent minimum (Q1  1.5*IQR) and maximum (Q3 + 1.5*IQR). IQR = interquartile range; 15, 14 and 15 images were analysed for SCR, si-
uc.291 (1) and si-uc.291 (2), respectively; *P < 0.05; **P < 0.01, Student’s t-test.
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Figure EV4. Uc.291 protein microarray.
A Schematic depicting high-throughput analysis performed to identify uc.291 protein interactome.
B Protein array analysis showing the top 20 chromatin-related candidates; see also Appendix Table S2.
C Reproducibility between the two human recombinant protein arrays spotted with 50,000 different proteins. (Pearson’s correlation = 0.76; F-B > 0).
D Area under ROC curve (AUC) to assess Global Score [34] ability to separate proteins interacting with uc.291 from those that are non-interacting. The F-B score was
employed to select different groups of high-affinity (top ranked) and low-affinity (bottom ranked) interactions reported in the array: (1) RBP, (2) chromatin-related
and (3) unfiltered (i.e. without selecting by category). In all cases, Global Score performances increase from poor signal (top/bottom 200) to strong signal (top/bottom
10) interactions, showing AUCs that raise from 0.60 to 0.80.
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Figure EV5. Negative controls for RIP, CLIP and ChIP.
A RT–qPCR amplifying the lncRNA FAM83H-AS1 used as negative control in the RNA-CLIP experiment (Fig 4C). Note that FAM83H-AS1 resulted expressed in HEK293E
(Ct mean in the input = 26.3, data not shown) but was undetectable in all the immunoprecipitated samples (IgG, SMARCC2, ACTL6A). The same samples of Fig 4C
were used (n = 3 technical); n.s. = not significant, Student’s t-test; HEK293 = human embryonic kidney 293.
B FAM83H-AS1 was used as negative control for the RIP performed in HEKn (Fig 4D). On top, RNA sequencing in HEKn (from Ref. 8) showing FAM83H-AS1 expression is
unchanged during keratinocyte differentiation. On bottom, RT–qPCR confirming FAM83H-AS1 is not modulated during the in vitro differentiation process (left
histogram; same samples of Fig 1B (n = 4 different human donors) were used) and it does not interact with ACTL6A (right histogram; same samples of Fig 4D (n = 3
replicates on 1 human donor) were used); n.s. = not significant, Student’s t-test; DD = days of differentiation.
C On the top, end-point PCR of TATA-box-binding protein (TBP) promoter after BRG1 chromatin IP in proliferating HEKn. On the bottom, end-point PCR of TBP promoter
after BRG1 (upper agarose gel) and BRM (lower agarose gel) ChIP in differentiated HEKn silenced for uc.291. The same samples of Fig 5 were used.
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Appendix Figure S1. Characterization of uc.291 transcript by complementary DNA (cDNA)
“walking”. By using a multiple primers amplification approach we defined the length of uc.291 transcript.
Primers were designed on 3’ and 5’ side of uc.291 conserved sequence at specific distances. “0 bp”
represents the amplification of the genomic reported uc.291 length (424 bp in UCNEbase). (A) Scheme
of the walking approach; (B) PCR fragments obtained using the blue primers reported in (A); (C) PCR
fragments obtained using the green primers reported in (a); (D) PCR fragments obtained using the red
primers reported in (A).
5’CTGGGCACTTAGCTCTCCACTTTAATTATTCATCCTTATGAAGAAAAATTTCCCCCGTGTGCTTTATTGTCCTCCAGC
CCCGACCTGAGCTCACGCAGACTCTTCCTTCTTTCCCTCCCCAAAGTGGCTTGTGTGTCGAAGGGCTTTCCACTGGGGTG
CTTATTCCATTTATGCCTTTAGTATGCATTTTGTGTTCTGCCAAGGGGGTCAGGAGGGCACATGGAGAAGCCAGATGGCT
TACCTCTTCCCTCAGGAAACACGCCGCTATTTAGCTGGGCACCTTCCCAACTCAAGGCGGGGTGAGATTCCACTGTTGGA
GAGAGAGTTGGTTCAAATGCCACTGTCCCTGAGATCACAGCTCCAAGTTCCTCTAGGCTATGCACTTTTCTACTTCTCTG
CCACTTGCTGGAGTTTTCTGCCAGAAACAGCCTTTTAGGAGATATTAGAAAGGGGGGTGGGAAGGGAGGGATGGGAAAAA
GCAACTCTTGTTATTTATGGTCCTCGTTCAGGCACAAGTTTCTGTTATTTTAATCCGGCTGAAATAAGAAACCATAATCC
ATGGATGAAAAGATGGTGGACAAACTCAGTTAAATCTTGAGCACCCTGAGGATGTGTGTTTTTCCCTATTTCTGGTTTTT
GACGTTCCTTCCCTGCTGCCATTTCCCAACTTTAACTTTTGAAAAGCCAAGCAGTTTGGCTGGCCAGGCCCAGGGAACTT
ATTTGTATGCAGCACAAATTTCAGAATCTGTTCTCAGCCTGTGCCGAGTGAAAAATGGCCTGCATTTTCTTGATAGCCCA
TGTGGTTGTAAAGAATAAATGGCTAATGAATTACAGATGAACATTGACGCAAATTAATCTTCCCGCTGTCCCTGGGTTAT
ATGGCAGCCATTTAAAAGTTTAATCAATACACTAAAGTTGAAAACATGCAGGCACTGCAGTTGTTTGGATGTAATAAACA
TCAGAGGGAACCGGGAGGTTTGCACCCAGTCCATGTATCATAATGACAGGTATTTATGTTTAATGGACTAAATATTTTTT
ATTGGAAGGGAGCAAATGTCAGCTTAACTTTGTGAGCCCCGCATTCAACTTTCCTTTGAGGTTGGTGAAAGACGGCTGAC
GTGTCATTGGAAATGAAATGTTAAGGGAGAAAAAAAGCACAACGGAGACAAAGCGAGGATGGGAGCCGTTTGGAGACGTG
GTGCAGCGCTTACATTCTGCAGCAATTCATTAACGAAAACGTAAACTCTGATATTTCTAATGTTGCTGTAAAATGGTTTA
CTAGGAACAACTTTAATGGTTATTAGTGAAAACAAGTACCCAGATCTGCCAGATATCCTTTTCAGTGCAGGCTTTTGTTT
GAAAACTCTTTACCAGGTCATATTTGCTGGAGATTTATAATTAGTCTTTTTCCTTAATGTGAGAAGTGGAGGAGAAACAG
CGTGATGGCTCTCAGCTCTTGTATTCCATAGATCTTTCCTTTTGAACGGTGTCCAATGACTTCGAATAACCATGTGTTCT
CTTTTGGAATACTTATATCTTAATTACTTTTCAAGTCAATATTTTGTACCTCTGCCGTGAGTCTGGAAGGACCAGGGAGC
TAAAAGAGAAAGGAAATTGCCAGTGGCAGTGCCATCTCGCTGGACAAAAACAGGCTGAGACACAGGAGAGCAATGGCTTC
ACTTGAACAGAAAAATACAGACTTAGTTCAGCTTTTCATTTTTTTTCCTCCACATATAAAATAAACTAAATATGTCAGTG
GAGCATGGGGTCTTAGAAAATAACACACACTTTATAAAAATAATTAGAAACGTTTTAGACAAAGGATATCGTGTTTTTAA
TGTCCCTTCTGCAACCAATTGTCTCAGGTCCTCTTCAGTGTCTGAGGGCACATTCAATGGCAGGGCTTGGAAGAAAATTA
TTCAGTAGATAGCAAGATGAGGCTGAAGGATGAGAAAAAGGGACAGGGGTTGTGATACTTATCCAGTGTTCAGATCTTGC
AAAAGATATGAATTGCACCTTTTTATGTGTTAAATAATTTTGTTAAAATCACAAGAATTTGTGTTTCTAATGGGCCTAAG
TTTCATAGGTAATCAGTATTATGTGATACTAAATTAGTAAACCAAACTGATGGGTTCATTGGTCCTTCATCATCCCTTAA
GCAAAATGGGGAGAAACTTTCTGTTATGAAAACCGAAGCATGGCTCACTGTTAACCATGATGACATCTCACCCACTACTG
CTCCTGAAGTCCTAAACTCTATTTTTCTTCCTACCTCTTTCTACCCTCTTAGAGGATTGAGTCCTTTACCTGTTTGTTCA
CTTTGTGTTTCCGCCGTGTGAATATAAGCTCCACAGTAGGGGGTAGGAGGCAAGAACCTGATTTTCTTCTTTGCTTCTAG
TGTCCTGGGGCCTGGCCTATAATAGGTTCTTGTAAATGGCAGGTAAGTGAATGGCGGACTACATTTCTTATGGTCTTTAG
TAATTTATAACTCCGGCTATTTTTTTTGTTAGTCAGTATGATTTCTAGTCACTGTGTTAGTTGTTTTACATATAATACAA
TACTTGATCTTAGTTGTTAACTCTAGAAGATAAGAGTTATTATCTTCATTTTATAGAGGCAAAAACTGATGTCAAGAGAA
TTGAAGCTAATTATTTGTGGTTACTGTTAGTATGTAGCAATTCCAGAATTTGAATCCTGACCTGTTTGTCTCTGTATCAG
CTATACAGTACTCCCCAAATTCCTGTCACTCATCTTGTCCCTGGGGATTAAAATCTCATTAAGTGACCACAACATTTAAT
TCTAGACTATAACCAGCCAGCTCCCCAACTGGCTGATAATGAACAGAAGTATTAGATTCACAATTTGCAACCTAAACCTG
GTGTCCTGAGTCCTACCTATAGAAAGCAATCTTTGACTGTACAAAAGTAGCACATTGGCTATTTGATGATGGGTGATATG
TCACTCAAATATGTGTGTTCTGTGGTCTAGGGAAATACAAGGAACTCTCTCAAATCATGAGAAAAGTGTTCAGCAACAGA
AATCTAACAAATAGTGACTGAAATGCATAGGCATTAATTTCTTCACTCAGAAGTGAGAATGGAGGTAGGCAGCCCAGGAC
AGTGATAGTGGCTGAAAGAGCAGATCAGTAGGCACCCAGGTCCTTTCTGTCTTTCTGTCCTACTACCTTTTCAGCATGTG
CATTTTAGCCTCATGGTCTCAAAATGGTTGCTACTGCTCCTGGCATCATTTCCTCACCCAAAGCAAGATGAAGAAGGATG
TCTTTCCCTTATGAGGCATTCGCTTTTCATTTGTGGATAGACAGCTTCCTAAAGATGTCTGTCTCTTTCTCATTACCCAG
ATCATGTCATTGGGAGGCTGGAAAGTCAAATGTTTCAGTTTTCATGCTGTTATAGTAGAGGAAGGCAGGATAAAAGGGAG
CCAATGCATAGTGTCTCCTATGTAAGATAAATCGCATTTTTTGTATACCTAATAAAGACTTGAAACTTTGCTAGATGCCA
TATGCACATCAACTTATATCATGTTTACAACCACCTTGTTACAGAAGAGTATTTATTCCCATTACACTAAGAAGAGGTGA
TCTCATTGTTCAATTCCCACCTATGAGTGAGAATATGCGGTGTTTGAAGGGGAATATCACACTCTGGGGACTGTTGTGGG
GTGGGGGGAGGGGGGAGGGATAGATTGGGAGATATACCTAATGCTAGATGACGAGTTAGTGGGTGCAGCGCACCAGCATG
GCACATGTATACATATGTAACCTGCACAATGTGCACGTGTACCCTAAAACGTAAAG 3’
3
Appendix Figure S2. Uc.291 transcript sequence. Uc.291 complete sequence (3816nt) characterized
by cDNA walking followed by sequencing of the PCR fragments obtained. Ultraconserved sequence is in
red, predicted ACTL6A binding sequence is in light blu.
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Appendix Figure S3. ACTL6A expression during keratinocyte differentiation. (A) IF staining of K14
(basal layer marker) and ACTL6A in uc.291-depleted, si-uc.291(1) and si-uc.291(2), organotypic human
epidermis compared to scramble control (SCR). Bar: 25um. One representative experiment of three is
shown. (B) Immunoblot showing ACTL6A protein levels in HEKn cells transfected with scramble
sequence (SCR) or si-uc.291(1) and si-uc.291(2) oligos and collected at proliferating (0 day) or
differentiating (3 days of differentiation, DD) conditions. β-actin was used as loading control. (C)
Immunoblot showing ACTL6A protein levels in HEKn cells collected in proliferating (0 day) or
differentiating (3, 6, 9 days of differentiation, DD) conditions. β-actin was used as loading control.
5Probe for 
T-UCR
Fold-
change 
Parametric 
p-value FDR Description
uc.262 6.9380217 5.00E-07 0.0005516 CAGGCTGAGTACAAATTACTATGCAAGGGAGGCTGAGGGT
uc.283 3.9902288 0.003973 0.0439591 CAGGGGCGCGGGATTGGATCAAATCACATAAACTGCAAAA
uc.145A 3.4355936 0.0025296 0.0367763 TCCCATCCACGCGCCTCATACATATTGATTTCTGACACCA
uc.36 2.935153 0.0042701 0.0455497 ACTTTCCTTGTGTGCTTGCACTATAGGTTTGGGACTGACA
uc.88 2.6496588 0.0053214 0.0514358 GGAGGGAAGCAGAAGTCGGGAAGAAAAGAGAAAAGCAGCA
uc.231 2.4696586 0.0142377 0.0922464 TGTGCATGTCAGCAGAATTCATAAGAACTTACAAAATCTT
uc.291A 2.3985146 0.0144979 0.0932284 TGCCATATAACCCAGGGACAGCGGGAAGATTAATTTGCGT
uc.473A 2.2716886 0.0023525 0.035347 CAGACACGGGGAGACACAACAGCACAGAACAGAGAACAAA
uc.220 2.1861354 0.0191878 0.1134554 TCAAGATTTGCCAAACCACTAACCGCATGTATCATTTGCA
uc.339 2.1658364 0.0007872 0.0230286 ACAGGAATGTAATTTTGCCCGGATGAGGCCCCGAGTTTAA
uc.77A 1.9122857 0.0158713 0.0992502 TCTTGGGAGCAGTGTGACAGAAACAGAGTGTGGCGAGAAC
uc.117A 1.8411175 0.0018504 0.0321861 AAACTTGTTTATTAAGATGGGCTGGAGGCGCTGGTGTGCA
uc.170 1.661361 0.0060615 0.0552691 ACACAGGAACAAAGCAAGAGAACAGAAACTCAGAGGCAGA
uc.346 1.6574337 0.0007029 0.0218725 TTCGGAGGCGGCTTTTCTTATTCAAAACAGGCCCACAATG
uc.142A 1.6263274 0.0016429 0.0308253 GTCACACCCGAACCGCCAACAAAATTATCTTAAGCTGCCA
uc.388A 1.5296091 0.0099989 0.0733348 AGCAACACACCATTTCACAGTCTATCGGGCACAAACACAT
uc.20A 1.4471174 0.0436931 0.2063864 CTTGGTGAGGTTTGGGCGGAATAAAGAAAGGTGTTGGTGG
uc.110 1.4082587 0.0031046 0.0398286 ACAAGTTGCTGTTAATTTAGTGCAGGGAGGACGGGATGGA
uc.398A 1.3920305 0.0497388 0.2267608 GGATCGGGAGGAGGAGAGCCAGCGACCACAAAGAAGACAG
uc.478 1.3431458 0.0239285 0.1326632 AAACAAATGGTGGTACGACAAAGGAGAGTGCGGCAGCGGG
uc.217A 1.276802 0.021647 0.1232889 AAAGCACCCTTCACAAAGCCACAAACAAGAAGCAGGACAG
uc.208A 1.2115439 0.0348729 0.1738692 TCAATGAAGAATGAAGAGAAGTAGAAAGCAAGAGTGAAGT
uc.310A 0.65047 0.0210915 0.1214111 GGCCTGTCTCTCCTCTTCTTTTTCAAACCAAATTCTGCTT
uc.369 0.6353444 0.0467179 0.2170893 TGATCTCATATTAAATTTTCCCCTGAATCCGCCCCTTGGC
uc.198 0.6342153 0.0182638 0.1091729 CTGGTGACAAGTGAAATTGCTGTGCGCCTCATTTAGCTGT
uc.262A 0.6117229 0.0442415 0.2085941 ACCCTCAGCCTCCCTTGCATAGTAATTTGTACTCAGCCTG
uc.16 0.6081178 0.0409966 0.1964124 CTTGTTCAACACAGAGCTTAGAAACCCTCCTTCCACTCCC
uc.478A 0.5942682 0.0280721 0.1492947 CCCGCTGCCGCACTCTCCTTTGTCGTACCACCATTTGTTT
uc.352 0.5837183 0.0263843 0.1424184 TTTAAAGGCCAAGTCTAAAATAGATTTGCACCCACGCCCC
uc.242 0.5766099 0.0308061 0.1585047 TTTAGTAGTTCCGCTATTCTGCTTAACATGTGGCACCCGT
uc.138 0.5757989 0.0400969 0.1932085 CTGACTTCTTTCATCTTCCCCACTTCACACAAATTGCTCA
uc.28 0.5717847 0.0282912 0.149858 AACTATATACCAGGCCCTGCTGAAAATACCACCCAACAGT
uc.462 0.5621613 0.0064514 0.0572034 GGTGGGTGGAGAGACGAAGTCAGGGCTGTTTGTTGAATAT
uc.452 0.5604607 0.0385909 0.1877993 AGCGTGTTTCTAATGCTATTCACCTGCCTTTGATGATTGA
uc.346A 0.5596938 0.0026415 0.0374468 CATTGTGGGCCTGTTTTGAATAAGAAAAGCCGCCTCCGAA
uc.325 0.5579312 0.0104034 0.0750892 GGGGTTTTGTTGTCAGAGTAGTTCCCGCCTCATGTTTTGT
uc.151A 0.5475617 0.0166494 0.1023798 TCTTGCTCACCTGGTCAAACACCCATTCCTCACTGCATTT
uc.390 0.5450069 0.0322261 0.1638461 AATTTAGTCAATTACTGTTTCAGCCTGCAAGCCTCCTGGG
uc.396 0.5407496 0.0161342 0.1001554 CATCTTGCACAGCTGCGCCCAACTGATTAAATCCTCACAA
uc.77 0.5379875 0.0382952 0.1867631 GTTCTCGCCACACTCTGTTTCTGTCACACTGCTCCCAAGA
uc.412A 0.5237442 0.031904 0.1631937 TTCAAATCCACACAAGCCTGCCACTTGCACTAGTCATCCC
uc.21A 0.5211857 0.0325936 0.1651708 ACCCATAATTTCTCATTTCCCAAACCTCACACATGCTGAA
uc.465A 0.5019852 0.0026524 0.0374468 TTCTCTCATCTCCCGCAGCTTAGCACCTGTCTTTGTTTGG
uc.400A 0.497497 0.0270436 0.1454441 AATCATCTGACACAAAGATAATTGAGCCAGCCTCTGCCAC
uc.457 0.496534 0.0180181 0.1085937 AGACATATTCCAGATCACAACCTTCCCAGAATCCTGCCCT
uc.268 0.4928927 0.0027834 0.0383176 ACTATCATCACAACCCTCATTGTTCCATCTCTGCCCTCCC
uc.129 0.4880591 0.0251525 0.1374754 CCATTGCCATCATGTGCTCGCTGCCTGCTAATTAAGACTC
uc.223A 0.4698592 0.0008607 0.0242558 GGCTGATTTATGTTGTCATTCCCTCTCACCAGTCCTGCAT
uc.373A 0.46421 0.0193354 0.1138975 TTGAAAGGAGACAACATTGTCCCGATTTCCCACTGCGACA
uc.473 0.4634708 0.0022747 0.03482 TTTGTTCTCTGTTCTGTGCTGTTGTGTCTCCCCGTGTCTG
uc.133A 0.4487399 0.0259639 0.1407152 ACTTTCCGATTTAATTTCCTCCATGCCCTTGACATCCACA
uc.476A 0.4466684 0.0276283 0.1476632 GCTGATTGATGGCTCTCTCCCTCACTGCTGAAGGCTGTAT
uc.422 0.4430617 0.0099478 0.0730988 GAGATTCTGCATTACTACACCTCAGTGCCTGCCTGGTTCC
uc.250 0.4364047 0.0070389 0.0603978 GCAAATATGATTATACACTATCAAACTGGCACCACCAGGC
uc.10A 0.4228508 0.0180147 0.1085937 TCTGCATCTCCTAATGGCCTCTGCTCCTCTACACTCAATT
Continue on the next page
6Appendix Table S1. Modulated T-UCRs during keratinocytes differentiation
Summary of Results
Sorted by p-value of the univariate test.
Class 1: differentiated; Class 2: undifferentiated.
The genes are significant at the nominal 0.05 
level of the univariate test
Description:
Number of classes: 2
Type of univariate test used: Two-sample T-test
Nominal significance level of each univariate test: 0.05
uc.335A 0.4227937 0.0146008 0.0936515 CAGCAGAAGCAGGTCTCAGGTCCCAGTGGTTAATGTAGTG
uc.281A 0.4197648 0.0082006 0.0648906 GCCTTTATTGGAATTCTGAAACCTCTCTGCCTCCCTGGCT
uc.391A 0.4037248 0.0289005 0.1520426 AAATTATTGCATTGCTGGTGGCAATTTGTGGGCATGTGTT
uc.305A 0.3992737 0.0028265 0.0385672 CGGCAGGCTCTTCCCATCTTCCCATCCATTCATCATCTCG
uc.161A 0.3980419 0.0007734 0.0228909 CCATCATAATTTGTTCATTTGGTGCCCATCAGCCCAGCCT
uc.177A 0.3960284 0.048816 0.224542 CACAATTTCAAAACTGCCTGCTAATTTCCACCACCTGTCA
uc.159A 0.3946312 0.0031571 0.0401024 GGTCCTCCACAGTCCCAAATTCACCCGTTTAAGCCATAAT
uc.416A 0.3747073 0.0023867 0.0355154 GCTGCCATGCACACCGGCTCTTACGGCTACAATTACAATG
uc.134A 0.3737976 0.0088282 0.0679086 GCTCATAAATTACTGCTCTTTTGTTGCTGGCTGGCCTTGT
uc.1 0.3736053 0.0064382 0.0571786 CACTTCCCCACCGCAGGCTTTGCTGAGCAGTTTTAGTATC
uc.181A 0.3669021 0.0016712 0.0308772 GAATGAGCAGGCCCCAAGGTGTTTCAACTGGAGTGTTTTC
uc.349 0.3633513 0.003553 0.0415567 ATGTTTTCCACAGCCCAAGACCTTTGGTGCATGCTTTTGA
uc.266A 0.3471284 0.0207761 0.1199206 AGACCACTTCAATTTCAGCTTCTGCCAGCCTCGTTTGAGA
uc.136 0.3449797 0.0143047 0.0925777 CAATAACGCTTTGATAGATCCCTGTCTGCCCGGTGCTTGA
uc.411 0.3341136 0.0003292 0.0146432 ACCCATTTGTCACCCAGCATTTCCCTTTGTGTATAGAACA
uc.164A 0.3221855 0.0045111 0.0470165 TTACCACATGCTGTCACAGTTAGCTCAGCCAGGTCTTGTT
uc.329A 0.2860004 0.0025932 0.0370876 TGTAGTCATCAAGTGAGAAAGACATCCTCCTCCTGGCTGC
uc.232 0.2818089 0.0006993 0.0218725 AAGTGTTGTGTCAATAACGCAGCCAAGATCTCGCCAATCG
uc.63A 0.2714599 0.0012258 0.0280916 CAGTGTTTGCCTGTTTGCTTGCCTGGTAAATTTTGCTTTT
uc.257 0.2624234 0.0002364 0.0124403 CTGATGGATTCCCAGGCCCATTGCTGTCACTGATGAACTA
uc.338A 0.2565722 0.0010626 0.026549 CTGTCGCTGCCTGTGCTGTACCTGTCCTGTGGATAAATAG
uc.183A 0.250974 6.32e-05 0.0068978 CCCAGTGTCAGATGTCTCCAGGTGCCTCTCTTCTTTCTTG
uc.252A 0.2239623 0.0002429 0.01259 TCTCAGGAAGCCCAGCCAATTAAGGACTTGACCATATTGA
uc.204A 0.1862553 2.7e-06 0.001604 GCTCTAATTTACAAGCCGCCTGCCTAATGAATTGTCTGGG
7Gene Symbol Expressed in epidermis*
BATF2 yes
SMARCE1 yes
ACTL6A yes
TRIM16 yes
TADA2A
CENPO
DEK yes
CRTC2 yes
UBE2B
BRCC3
CHCHD3
SETMAR
CHD2
SMARCC2 yes
VEGFA yes
PRMT3 yes
C17orf49 yes
GATA2
MRGBP
BMI1 yes
CPA4 yes
PRMT6 yes
CHCHD2 yes
DCAF17
SMARCD3
SETDB1
EYA1
UBE2U
ZCRB1
GATA3 yes
EPC1
PRKD2 yes
ATXN7L3 yes
HJURP
CENPA yes
SIRT1
PRKCA
HIST1H1C yes
ZNF451
PHLDB1 yes
Appendix Table S2. List of ranked candidates interacting with uc.291.
Table showing the top 40 uc.291 interactors derived from the protoarray. See also Figure 4 
and  Figure EV4. * The expression in human epidermis was extrapolated from The Human 
Protein Atlas (http://www.proteinatlas.org).
8cDNA Walking
Name Sequence 5'-3'
F-50 TTCCCAACTTTAACTTTTGAAAAGC
R+475 AAACGGCTCCCATCCTCGCTTTG
F-100 ATGTGTGTTTTTCCCTATTTCTGG
R+525 CGTTTTCGTTAATGAATTGCTGCAG
F-150 GGATGAAAAGATGGTGGACAAAC
R+575 AGTTGTTCCTAGTAAACCATTTTAC
F-200 CACAAGTTTCTGTTATTTTAATCCG
R+625 AAAGGATATCTGGCAGATCTGGG
F-250 AGGGAGGGATGGGAAAAAGCAAC
R+675 TCCAGCAAATATGACCTGGTAAAG
F-300 GTTTTCTGCCAGAAACAGCCTTTTAG
R+725 GCTGTTTCTCCTCCACTTCTCAC
F-350 CCAAGTTCCTCTAGGCTATGCAC
R+775 CACCGTTCAAAAGGAAAGATCTATG
F-400 CTGTTGGAGAGAGAGTTGGTTC
R+825 AAGATATAAGTATTCCAAAAGAGAAC
cDNA Walking UP
Name Sequence 5'-3'
R5'-UP GGCTGTTTCTGGCAGAAAACTCC
F-456 CGCCGCTATTTAGCTGGGCACC
F-505 GGAGGGCACATGGAGAAGCCAG
F-620 CAGACTCTTCCTTCTTTCCCTC
F-647 GTCCTCCAGCCCCGACCTGAGC
F-685 CATCCTTATGAAGAAAAATTTCCC
F-715 CTGGGCACTTAGCTCTCCAC
F-732 AACTACAGTGAGGCCTGGGCAC
F-861 GAGTTGCTGCCTTGTACAGCTG
cDNA Walking DOWN
Name Sequence 5'-3'
F3'-DOWN CTTTACCAGGTCATATTTGCTGG
R+875 TCCTTCCAGACTCACGGCAGAGG
R+923 GCGAGATGGCACTGCCACTGGC
R+1060 CTAAGACCCCATGCTCCACTGAC
R+1177 AATGTGCCCTCAGACACTGAAG
R+1288 CTTTTGCAAGATCTGAACACTGG
R+1440 GGGATGATGAAGGACCAATGAAC
R+1578 CTTCTAAGAGGGTAGAAAGAGG
F3'-1500-DOWN CCCACTACTGCTCCTGAAGTCC
R+1826 CAACTAACAGAGTGACTAGAAATC
R+2118 CAGCCAGTTGGGGAGCTGGCTGG
R+2400 CCTGGGCTGCCTACCTCCATTC
R+2664 CCAGCCTCCCAATGACATGATC
F3-2700-DOWN GGATGTCTTTCCCTTATGAGGC
R+3040 CTGGTGCGCTGCACCCACTAAC
R+3100 CTTTACGTTTTAGGGTACACGTG
R+3200 GTCAGACCTGATAATTTAGGGC
Appendix Table S3. Primers list used in the cDNA walking experiment (see also 
Appendix Figure S1).
9Name Sequence 5'-3'
T-UC291 FW GCGTCAATGTTCATCTGTAATTC
T-UC291 REV CTGTTCTCAGCCTGTGCCGAG
T-UC183 FW TGCTTCTTCTCTTCCTTCCTTTTTG
T-UC183 REV TGCTCTCTACCAGGTTGGCG
T-UC257 FW GCTGATGGATTCCCAGGCCCATTG
T-UC257 REV GTTCTGATCTTGAGGTAATTAGCC
T-UC338 FW AGTGAGCCTTGGAGACTGAACATCC
T-UC338 REV ACAGCCCTGGAGACTGAAATCCTC
T-UC63 FW CAGTGTTTGCCTGTTTGCTTGC
T-UC63 REV CCTGTTGCTTTCTTTCTGTTCCTC
T-UC36 FW AAATGTGTGTGAGTGCAAGCAG
T-UC36 REV GGGTCATTACCGCATGAAGGCC
T-UC88 FW TGTCAAAACTGCCAGGAGCAAG
T-UC88 REV GCCAATCTGTCACCGTTCAGC
IVL FW CAGGTCCAAGACATTCAACC
IVL REV CAAGTTCACAGATGAGACGG
KRT10 FW AGGAGGAGTGTCATCCCTAAG
KRT10 REV AAGCTGCCTCCATAACTCCC
LOR FW CTCTGTCTGCGGCTACTCTG
LOR REV CACGAGGTCTGAGTGACCTG
U6 FW GTGCTCGCTTCGGCAGCACATATAC
U6 REV AAAAATATGGAACGCTTCACGAATTT
ACTIN FW GTTGCTATCCAGGCTGTGC
ACTIN REV AATGTCACGCACGATTTCCCG
LCE1B FW GCTACAACTACACTAAGCAGTTC
LCE1B REV CTATTCTTGCCCTTTCAGCATCA
LCE1C FW AATCCAGGACCGCAAACTG
LCE1C REV TGGACCTGTGAGCCTCTCAG
LCE2B FW GGTTGACTAAACTCTGCCAGG
LCE2B REV GGCACTGGGGCAGGCATTTA
LCE2D FW CTGCAGAAGAGCTCTGGTACTG
LCE2D REV CTCCATCAAGCACAAAGTTCTG
LCE3A FW CTGAGTCACCACAGATGCC
LCE3A REV CTTGCTGACCACTTCCCCTG
LCE3C FW CCAGTTGTCCCTCACCCAAG
LCE3C REV CCGGAGCTTAGAGCACAGTC
LCE6A FW CAGGGAGCTGAAAAGCCAGA
LCE6A REV GAGGGGAGCATTTGGGAACA
SPRR2B FW AGGAACCTTGGCTTTGTCAGT
SPRR2B REV AGCTCATGCCCAGGTGAAAG
KPRP FW CCTGAAGGACTGCTTGCCTG
KPRP REV CTGGGCAAAGGGGGATTGAG
HRNR FW GAAGTGCTCAGGGCAAGAT
HRNR REV GCACCTCTGCTCTTGGACAT
FLG FW CAATCAGGCACTCATCACAC
FLG REV ACTGTTAGTGACCTGACTACC
TBP FW TCAAACCCAGAATTGTTCTCCTTAT
TBP REV CCTGAATCCCTTTAGAATAGGGTAGA
Appendix Table S4. Primers list used in the RT-qPCR
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Name Sequence 5'-3'
LOR FW TCTCCTTTCCTGCATTCGCT
LOR REV TTCGTTTGCCAGCCATTCCT
FLG FW CCAAGGCAAAGGGCAAGATTC
FLG REV GCTACGCTGTCTAGCTCTCTG
LCE1B FW TGAAGGAGGGAGCCTCAAGA
LCE1B REV TACAGGTGAACATGGCAGGC
TBP FW CTGACAGGTAAGGAGGACGC
TBP REV AGTTACCTGACCTCTCCCCC
Appendix Table S5. Primers list used in the ChIP experiments (see also Figure 5).
